FDA Rejects Regeneron's Eylea HD The US Food and Drug Administration (FDA) has rejected a prefilled syringe version of Regeneron's Eylea HD (aflibercept) due to manufacturing issues.
Regulatory Standards When Selling to the Indian Market Foreign companies entering the Indian market must navigate key regulatory requireme…
Circus Show Combines Culture and Artistry A spectacular stage show combining live music, dance, gymnastics, and traditional circus perform…
ESMO 2025: Data, decisions, and the future of oncology Leading clinicians, researchers, and pharmaceutical innovators gathered at the ESMO…
In the Maldives, Luxury Takes Many Shapes For travelers to this dreamy archipelago, helping keep its waters and beaches pristine is a vaca…
Allied Nations Invest in Critical Minerals Supply Chains Western governments have committed $8.5 billion to accelerate mining and processi…
Gmail Data Breach: 183 Million Accounts Exposed Over 183 million Gmail accounts were exposed in a massive data leak, considered one of the…
Hazbin Hotel Season 2: Release Date and Details Prime Video's musical comedy series Hazbin Hotel returns for Season 2, with new episodes r…
Vinicius Junior to Chelsea: A Potential Threat to Current Forwards Chelsea are reportedly monitoring the situation of Vinicius Junior, a B…
Rooftop Lease Dispute in RiNo A rooftop bar, Rose, located atop The Penrose apartments in RiNo, is involved in a legal dispute with the bu…
Revival of 14er Brewing in the Mountains A shuttered RiNo beer brand, 14er Brewing, is set to be revived in Poncha Springs under new owner…